Clinical Trials at the Innovation Center for Urologic Research and Education

The Innovation Center for Urologic Research and Education (iCURE) currently has one active clinical trial which evaluates a drug designed to treat kidney stones specifically caused by enteric hyperoxaluria (EH), or an over-absorption of oxalate from foods that increases the amount of oxalate excreted in the urine.

inNOVate

InNOVate, a stage two clinical trial, is designed for patients with a diagnosis of EH following Roux-en-Y gastric bypass surgery—the changes to the stomach and small intestine after surgery are thought to increase the chances of EH. The inNOVate study lasts for up to 28 weeks and is administered in two components: a liquid form taken at the study clinic and a powder which is mixed into water and taken once a day for 28 days. 

To learn more about the trial, email Christopher Tucci, MS, RN-BC, CURN, NE-BC, FAUNA, operations officer, at [email protected] or 401-793-5400.